ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,760Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 32

$1.39M Total Retail Price of All Prescriptions

Rank: 2 out of 32

816 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 816 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 816 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 17,333 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 774 614 1 2
HYDROCODONE-ACETAMINOPHEN 735 494 S3 2 1
FUROSEMIDE 653 509 3 5
LISINOPRIL 603 504 4 3
OMEPRAZOLE 532 428 5 8
SIMVASTATIN 491 436 6 6
LEVOTHYROXINE SODIUM 477 438 7 4
POLYETHYLENE GLYCOL 3350 437 344 8 46
METOPROLOL TARTRATE 417 317 9 7
TRAMADOL HCL 391 321 10 13
PRAVASTATIN SODIUM 368 242 11 10
POTASSIUM CHLORIDE 347 280 12 14
METFORMIN HCL 337 235 13 9
WARFARIN SODIUM 323 218 14 25
RANITIDINE HCL 279 200 15 12
CITALOPRAM HBR 276 228 16 27
LANTUS 273 155 17 29
DONEPEZIL HCL 254 246 18 30
HYDROCHLOROTHIAZIDE 247 202 19 11
GABAPENTIN 243 181 20 16
ATORVASTATIN CALCIUM 232 172 21 15
NAMENDA 220 219 22 43
NEXIUM 211 150 23 23
FAMOTIDINE 210 169 24 47
ZETIA 209 177 25 91
RISPERIDONE 206 168 26 39
BENAZEPRIL HCL 199 171 27 88
TAMSULOSIN HCL 197 150 28 34
CIPROFLOXACIN HCL 193 158 29 35
DIOVAN 185 157 30 42
ALLOPURINOL 185 161 30 26
CYMBALTA 178 111 32 44
METOPROLOL SUCCINATE 166 138 33 18
CARVEDILOL 161 109 34 28
DOXAZOSIN MESYLATE 158 130 35 80
LOSARTAN POTASSIUM 157 127 36 37
CLONIDINE HCL 155 121 37 31
CRESTOR 151 128 38 21
CLOPIDOGREL 142 117 39 38
QUETIAPINE FUMARATE 140 93 40 51
ABILIFY 138 119 41 122
JANUVIA 137 121 42 79
TRAZODONE HCL 137 90 42 53
LEVETIRACETAM 137 94 42 74
OXYCODONE HCL-ACETAMINOPHEN 134 61 S2 45 60
ISOSORBIDE MONONITRATE ER 134 128 45 49
HYDRALAZINE HCL 134 115 45 107
AMLODIPINE BESYLATE-BENAZEPRIL 134 118 45 55
ATENOLOL 133 124 49 17
LYRICA 133 97 49 68
FLUTICASONE PROPIONATE 131 97 51 58
DIOVAN HCT 124 118 52 61
FENTANYL 119 67 S2 53 63
ALENDRONATE SODIUM 117 105 54 82
SERTRALINE HCL 112 71 55 24
MELOXICAM 112 102 55 33
PLAVIX 111 88 57 64
SULFAMETHOXAZOLE-TRIMETHOPRIM 109 82 58 41
TRICOR 107 95 59 135
NOVOLOG 103 49 60 57
LEVOFLOXACIN 100 91 61 83
PREDNISONE 99 91 62 52
DIGOXIN 98 69 63 56
ZOLPIDEM TARTRATE 92 64 64 20
MIRTAZAPINE 89 77 65 50
COLCRYS 88 50 66 73
AZITHROMYCIN 87 73 67 32
CARBIDOPA-LEVODOPA 84 71 68 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 57 69 19
ACTOS 77 50 70 67
GLIMEPIRIDE 75 75 71 66
BENZTROPINE MESYLATE 74 56 R 72 126
IBUPROFEN 74 48 72 104
VENLAFAXINE HCL ER 72 62 74 152
FENOFIBRATE 70 68 75 155
DIVALPROEX SODIUM 69 20 76 71
METOCLOPRAMIDE HCL 69 42 76 93
CEPHALEXIN 68 52 78 48
VALPROIC ACID 68 58 78 158
VENLAFAXINE HCL 68 38 78 158
NAPROXEN 67 33 81 72
SPIRONOLACTONE 65 51 82 112
PROMETHAZINE HCL 65 45 R 82 59
ESCITALOPRAM OXALATE 64 50 84 89
LAMOTRIGINE 63 33 85 95
INSULIN SYRINGE 62 43 86 75
NIFEDIPINE ER 62 50 86 99
BACLOFEN 61 0 88 106
CELEBREX 60 54 89 134
FINASTERIDE 60 60 89 107
METOLAZONE 60 38 89 167
GLIPIZIDE 58 29 92 40
METFORMIN HCL ER 58 38 92 36
FLUOXETINE HCL 58 40 92 111
FLUCONAZOLE 57 31 95 174
CALCITRIOL 57 57 95 174
HUMALOG 55 43 97 129
LIPITOR 55 49 97 180
EXELON 55 41 97 117
LOSARTAN-HYDROCHLOROTHIAZIDE 55 42 97 45
AMOX TR-POTASSIUM CLAVULANATE 54 37 101 120
BENICAR 53 45 102 187
AMITRIPTYLINE HCL 52 41 R 103 90
SPIRIVA 52 45 103 107
TRILIPIX 51 51 105 190
CARISOPRODOL 51 28 R 105 93
COREG CR 51 39 105 190
LOVASTATIN 50 31 108 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.